insights_auto
Why is ALNOV down 4,15%?
Dive Deeperchevron_right
ALNOV:EPA
Novacyt SA
0,48 €
arrow_downward
-4,15%(-0,021) 1D
30 սեպ, 12:47:54 GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALNOV...
Open
0,51 €
High
0,51 €
Low
0,48 €
Mkt. cap
34,93 մլն
Avg. vol.
262,44 հզր
Volume
182,16 հզր
52-wk high
1,04 €
52-wk low
0,29 €
EPS
-0,39 €
Shares outstanding
72,59 մլն
No. of employees
216
Open
0,51 €
High
0,51 €
Low
0,48 €
Mkt. cap
34,93 մլն
Avg. vol.
262,44 հզր
Volume
182,16 հզր
52-wk high
1,04 €
52-wk low
0,29 €
EPS
-0,39 €
Shares outstanding
72,59 մլն
No. of employees
216
News stories
From web sources and news partners
Investing.com India
·
1 ժամ առաջ
Novacyt H1 2026 slides: revenue climbs 18% as margin pressure persists
Investing.com
·
2 ժամ առաջ
Earnings call transcript: Novacyt H1 2025 revenue rises 18% as margin slips
Yahoo Finance UK
·
4 ժամ առաջ
Novacyt Reports 18% First-Half Revenue Growth as Southern Cross Adds £1.8 Million
TipRanks
·
4 ժամ առաջ
Novacyt lifts H1 revenue on diagnostics growth and Asia-Pacific deal
Profile
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
About Novacyt SA